Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.046
Sell
RSI(14)
26.607
Sell
STOCH(KDJ)(9,3,3)
11.728
Oversold
ATR(14)
0.158
High Vlolatility
CCI(14)
-120.030
Sell
Williams %R
88.630
Oversold
TRIX(12,20)
-1.387
Sell
StochRSI(14)
100.000
Buy
GoodRx Holdings Inc
GDRX2.710USD
+0.090+3.44%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
924.58MMarket Cap
29.12P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of GoodRx Holdings Inc
Currency: USD Updated: 2025-11-21Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
GoodRx Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Buy
Current Rating
5.089
Target Price
+94.25%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
GoodRx Holdings Inc Highlights
StrengthsRisks
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 31.22, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.92M shares, decreasing 30.03% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 123.26K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.75.
Financial Health
Currency: USD Updated: 2025-11-21The company's current financial score is 8.73, which is higher than the Software & IT Services industry's average of 7.26. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 196.03M, representing a year-over-year increase of 0.40%, while its net profit experienced a year-over-year increase of 71.78%.
Score
Financials
7.50
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
10.00
Growth Potential
8.62
Shareholder Returns
7.54
GoodRx Holdings Inc's Company Valuation
Currency: USD Updated: 2025-11-21The company’s current valuation score is 8.41, which is higher than the Software & IT Services industry's average of 7.30. Its current P/E ratio is 31.22, which is 928.69% below the recent high of 321.17 and 1859.45% above the recent low of -549.32.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 95/484
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-11-21The company’s current earnings forecast score is 7.33, which is lower than the Software & IT Services industry's average of 7.59. The average price target for GoodRx Holdings Inc is 5.00, with a high of 7.00 and a low of 3.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
5.089
Target Price
+94.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
104
Total
7
Median
14
Average
Company name
Ratings
Analysts
GoodRx Holdings Inc
GDRX
15
Meta Platforms Inc
META
68
Alphabet Inc
GOOGL
66
Uber Technologies Inc
UBER
56
Netflix Inc
NFLX
51
Shopify Inc
SHOP
50
1
2
3
...
21
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-11-21The company’s current price momentum score is 6.46, which is lower than the Software & IT Services industry's average of 6.68. Sideways: Currently, the stock price is trading between the resistance level at 3.60 and the support level at 2.22, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.732
Sell
MA10
2.885
Sell
MA20
3.139
Sell
MA50
3.759
Sell
MA100
4.099
Sell
MA200
4.298
Sell
Institutional Confidence
Currency: USD Updated: 2025-11-21The company’s current institutional recognition score is 5.00, which is lower than the Software & IT Services industry's average of 5.79. The latest institutional shareholding proportion is 62.62%, representing a quarter-over-quarter decrease of 18.87%. The largest institutional shareholder is The Vanguard, holding a total of 9.19M shares, representing 8.71% of shares outstanding, with 8.67% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Hirsch (Douglas Joseph)
Bezdek (Trevor)
Columbia Threadneedle Investments (US)
Silver Lake Partners
Perot Investments
Dimensional Fund Advisors, L.P.
BlackRock Institutional Trust Company, N.A.
1
2
Risk Assessment
Currency: USD Updated: 2025-11-21The company’s current risk assessment score is 3.43, which is lower than the Software & IT Services industry's average of 4.90. The company's beta value is 1.50. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.50
VaR
+6.22%
240-Day Maximum Drawdown
+48.93%
240-Day Volatility
+66.96%
Return
Best Daily Return
60 days
+18.91%
120 days
+37.27%
5 years
+37.27%
Worst Daily Return
60 days
-10.64%
120 days
-20.05%
5 years
-38.91%
Sharpe Ratio
60 days
-3.01
120 days
-0.45
5 years
-0.49
Risk Assessment
Maximum Drawdown
240 days
+48.93%
3 years
+71.65%
5 years
+95.31%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.22
5 years
-0.20
Skewness
240 days
+2.45
3 years
+1.79
5 years
+0.40
Volatility
Realised Volatility
240 days
+66.96%
5 years
+72.90%
Standardised True Range
240 days
+8.56%
5 years
+27.95%
Downside Risk-Adjusted Return
120 days
-79.39%
240 days
-79.39%
Maximum Daily Upside Volatility
60 days
+86.43%
Maximum Daily Downside Volatility
60 days
+40.36%
Liquidity
Average Turnover Rate
60 days
+0.82%
120 days
+0.61%
5 years
--
Turnover Deviation
20 days
+275.38%
60 days
+90.86%
120 days
+41.69%
Peer Comparison
Software & IT Services
GoodRx Holdings Inc
GDRX
7.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ePlus inc
PLUS
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cognizant Technology Solutions Corp
CTSH
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
DOX
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Akamai Technologies Inc
AKAM
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Clearwater Analytics Holdings Inc
CWAN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of GoodRx Holdings Inc?
The TradingKey Stock Score provides a comprehensive assessment of GoodRx Holdings Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of GoodRx Holdings Inc’s performance and outlook.
How do we generate the financial health score of GoodRx Holdings Inc?
To generate the financial health score of GoodRx Holdings Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects GoodRx Holdings Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of GoodRx Holdings Inc.
How do we generate the company valuation score of GoodRx Holdings Inc?
To generate the company valuation score of GoodRx Holdings Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare GoodRx Holdings Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of GoodRx Holdings Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of GoodRx Holdings Inc.
How do we generate the earnings forecast score of GoodRx Holdings Inc?
To calculate the earnings forecast score of GoodRx Holdings Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on GoodRx Holdings Inc’s future.
How do we generate the price momentum score of GoodRx Holdings Inc?
When generating the price momentum score for GoodRx Holdings Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of GoodRx Holdings Inc’s prices. A higher score indicates a more stable short-term price trend for GoodRx Holdings Inc.
How do we generate the institutional confidence score of GoodRx Holdings Inc?
To generate the institutional confidence score of GoodRx Holdings Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about GoodRx Holdings Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of GoodRx Holdings Inc.
How do we generate the risk management score of GoodRx Holdings Inc?
To assess the risk management score of GoodRx Holdings Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of GoodRx Holdings Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of GoodRx Holdings Inc.
